Impact of interleukin-18 on Alzheimer’s disease [ 2017 - ]

Research Grant

Researchers: Dr Rodrigo Medeiros (Principal investigator)

Brief description Inflammation plays both protective and damaging roles in Alzheimer’s disease (AD), so to identify a long lasting and effective treatment, it is important that we better understand the underlying processes. Our studies implicate a cytokine called interleukin-18 (IL-18) as a factor that accelerates AD pathology. Here we propose to study the mechanisms by which this cytokine alters basic cell biological functions and how these changes affect AD pathogenesis.

Funding Amount $722,857.00

Funding Scheme Project Grants

Notes New Investigator Grant